# Sen-Jam at the NYSE — AI, Resilience, and What Comes Next | Sen-Jam Pharmaceutical

- Canonical URL: https://wefunder.com/feed/357455
- Entity ID: wefunder:feed_item:357455
- Published at: 2026-07-23 17:09:13 UTC
- Updated at: 2026-07-28 02:11:07 UTC

## Author
Christine Leonard

## Subject
Sen-Jam Pharmaceutical

## Content
Dear Sen-Jam Investors and Followers,Today was a milestone worth sharing.Our CEO, Jim Iversen, joined theCUBE for NYSE Wired's MedTech Unplugged series to talk about where AI actually earns its place in healthcare — not as hype, but as the engine behind medicines that survive regulatory scrutiny and reach real patients. You can watch the full conversation here: The timing wasn't incidental. Jim and the Sen-Jam team spent the same day at Decoding Bio's AI x Bio Summit — now in its fourth year, and one of the most sought-after gatherings in biotech this summer, bringing together the founders, investors, and scientists shaping AI's role in drug discovery.Both rooms reflected a conversation we've been having internally for years: what happens when AI isn't bolted onto drug discovery as an afterthought, but built around the biology itself?That's the thinking behind GALAXY AI and the broader ecosystem we've been developing — a computational platform built to decode resilience: the body's own capacity to resist, adapt, and recover from inflammatory insult. Mapped, modeled, and mined for therapeutic targets before a single patient enters a trial. Discovery and diligence fused into one pipeline — de-risking earlier, moving faster, and letting the science lead.It's why an 14-asset pipeline anchored in prevention-led, anti-inflammatory science looks less like a bet each day and more like a blueprint.We're grateful for your continued belief in this vision, and for being part of the journey as we build toward what's next.More to come soon.With joy,Christine